Dr. martin mengel
Freiberuflich, Founder, owner, Martin Mengel - global health consulting
Köln, Deutschland
Werdegang
Berufserfahrung von martin mengel
Bis heute 7 Jahre und 3 Monate, seit Apr. 2017
Operations Director
agence de medecine preventive
Director Health Policy and Institutional Development (HPID), WHO- Collaborating Centre: - Contribute to WHO promotion of systematic use of evidence-informed policy- in immunization - Collaborate with WHO on scaling-up such use of evidence, in particular through the creation and strengthening of National Immunization Technical Advisory Groups (NITAGs) - Facilitate the exchange of information within the immunization community Agence de Médecine Préventive (Funding: Bill&Melinda Gates Foundation)
Bis heute 7 Jahre und 4 Monate, seit März 2017
Founder, owner
Martin Mengel - global health consulting
Primary Investigator – Cholera Vaccine use in Endemic Settings (VacciChol): - Monitoring and evaluation of cholera vaccine campaigns in Africa - Assessment of different vaccination strategies to determine maximum cost-effectiveness and - Introduction of cholera vaccine into national control plans via National Immunization Technical Advisory Groups (NITAGs) (Funding Bill&Melinda Gates Foundation)
Bis heute 11 Jahre und 3 Monate, seit Apr. 2013
Team Leader - Water-Borne&Diarrheal Diseases
Agence de Medecine Preventive
Program Leader – Enteric Diseases - Coordination of all activities related to enteric diseases - Developing new proposals and partnerships - Participation in the relevant bodies and institutions dealing with enteric diseases, e.g. WHO: Technical Advisory Groups for disease specific surveillance-, intervention- and immunization strategies; GAVI: technical advisor for the global vaccine investment strategy.
Bis heute 13 Jahre und 4 Monate, seit März 2011
Primary Investigator
agence de medecine preventive
Primary Investigator – Cholera Vaccine use in Endemic Settings (VacciChol): - Monitoring and evaluation of cholera vaccine campaigns in Africa - Assessment of different vaccination strategies to determine maximum cost-effectiveness and - Introduction of cholera vaccine into national control plans via National Immunization Technical Advisory Groups (NITAGs) (Funding Bill&Melinda Gates Foundation)
2 Jahre und 1 Monat, Sep. 2008 - Sep. 2010
Epidemiologist
ECDC, European Centre for Disease Prevention and Control
Research, Outbreak investigations, Epidemic intelligence, teaching
Ausbildung von martin mengel
2 Jahre, Okt. 2008 - Sep. 2010
Field Epidemiology
National School of Health, Madrid, Spain
Epidemiology, Health Systems, Biostatistics, Field Investgiations, Study Design
8 Jahre, Okt. 1998 - Sep. 2006
Medicine
Bonn
8 Jahre, Okt. 1998 - Sep. 2006
Medicine
Bonn
Sprachen
Deutsch
Muttersprache
Englisch
Muttersprache
Französisch
Fließend
Spanisch
Fließend
Portugiesisch
Fließend
Italienisch
Gut
Niederländisch
Grundlagen
Griechisch
-